Role of P-glycoprotein in transplacental transfer of methadone

Tatiana Nanovskaya, Ilona Nekhayeva, Nedra Karunaratne, Kenneth Audus, Gary Hankins, Mahmoud Ahmed

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Methadone is the therapeutic agent of choice for treatment of the pregnant opiate addict. However, little is known on the factors affecting its concentration in the fetal circulation during pregnancy and how it might relate to neonatal outcome. Therefore, a better understanding of the function of placental metabolic enzymes and transporters should add to the knowledge of the role of the tissue in the disposition of methadone and its relation to neonatal outcome. We hypothesized that the expression and activity of the placental efflux transporter P-glycoprotein (P-gp) would affect the transfer of methadone to the fetal circulation. Data obtained utilizing dual perfusion of placental lobule and monolayers of Be-Wo cell line indicated that methadone is extruded by P-gp. Transfer of methadone to the fetal circuit was increased by 30% in the presence of the P-gp inhibitor GF120918 while the transfer of paclitaxel, a typical substrate of the glycoprotein, was increased by 50%. In the Be-Wo cell line, methadone and paclitaxel uptake was also increased in the presence of the P-gp inhibitor cyclosporin A. Moreover, the expression of P-gp in placental brush-border membranes varied between term placentas. Taken together, these data strongly suggest that the concentration of methadone in the fetal circulation is affected by the expression and activity of P-gp. It is reasonable to speculate that placental disposition of methadone affects its concentration in the fetal circulation. If true, this may also be directly related to the incidence and intensity of neonatal abstinence syndrome (NAS).

Original languageEnglish (US)
Pages (from-to)1869-1878
Number of pages10
JournalBiochemical Pharmacology
Volume69
Issue number12
DOIs
StatePublished - Jun 15 2005

Fingerprint

Methadone
P-Glycoprotein
Paclitaxel
Opiate Alkaloids
Neonatal Abstinence Syndrome
Cells
Cell Line
Brushes
Microvilli
Placenta
Cyclosporine
Monolayers
Glycoproteins
Perfusion
Tissue
Membranes
Pregnancy
Networks (circuits)
Incidence
Substrates

Keywords

  • Dual perfusion
  • Human placenta
  • Methadone
  • P-Glycoprotein
  • Transplacental transfer

ASJC Scopus subject areas

  • Pharmacology

Cite this

Role of P-glycoprotein in transplacental transfer of methadone. / Nanovskaya, Tatiana; Nekhayeva, Ilona; Karunaratne, Nedra; Audus, Kenneth; Hankins, Gary; Ahmed, Mahmoud.

In: Biochemical Pharmacology, Vol. 69, No. 12, 15.06.2005, p. 1869-1878.

Research output: Contribution to journalArticle

Nanovskaya, Tatiana ; Nekhayeva, Ilona ; Karunaratne, Nedra ; Audus, Kenneth ; Hankins, Gary ; Ahmed, Mahmoud. / Role of P-glycoprotein in transplacental transfer of methadone. In: Biochemical Pharmacology. 2005 ; Vol. 69, No. 12. pp. 1869-1878.
@article{1896d71f7066426e844452b845ad0f4e,
title = "Role of P-glycoprotein in transplacental transfer of methadone",
abstract = "Methadone is the therapeutic agent of choice for treatment of the pregnant opiate addict. However, little is known on the factors affecting its concentration in the fetal circulation during pregnancy and how it might relate to neonatal outcome. Therefore, a better understanding of the function of placental metabolic enzymes and transporters should add to the knowledge of the role of the tissue in the disposition of methadone and its relation to neonatal outcome. We hypothesized that the expression and activity of the placental efflux transporter P-glycoprotein (P-gp) would affect the transfer of methadone to the fetal circulation. Data obtained utilizing dual perfusion of placental lobule and monolayers of Be-Wo cell line indicated that methadone is extruded by P-gp. Transfer of methadone to the fetal circuit was increased by 30{\%} in the presence of the P-gp inhibitor GF120918 while the transfer of paclitaxel, a typical substrate of the glycoprotein, was increased by 50{\%}. In the Be-Wo cell line, methadone and paclitaxel uptake was also increased in the presence of the P-gp inhibitor cyclosporin A. Moreover, the expression of P-gp in placental brush-border membranes varied between term placentas. Taken together, these data strongly suggest that the concentration of methadone in the fetal circulation is affected by the expression and activity of P-gp. It is reasonable to speculate that placental disposition of methadone affects its concentration in the fetal circulation. If true, this may also be directly related to the incidence and intensity of neonatal abstinence syndrome (NAS).",
keywords = "Dual perfusion, Human placenta, Methadone, P-Glycoprotein, Transplacental transfer",
author = "Tatiana Nanovskaya and Ilona Nekhayeva and Nedra Karunaratne and Kenneth Audus and Gary Hankins and Mahmoud Ahmed",
year = "2005",
month = "6",
day = "15",
doi = "10.1016/j.bcp.2005.03.030",
language = "English (US)",
volume = "69",
pages = "1869--1878",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Role of P-glycoprotein in transplacental transfer of methadone

AU - Nanovskaya, Tatiana

AU - Nekhayeva, Ilona

AU - Karunaratne, Nedra

AU - Audus, Kenneth

AU - Hankins, Gary

AU - Ahmed, Mahmoud

PY - 2005/6/15

Y1 - 2005/6/15

N2 - Methadone is the therapeutic agent of choice for treatment of the pregnant opiate addict. However, little is known on the factors affecting its concentration in the fetal circulation during pregnancy and how it might relate to neonatal outcome. Therefore, a better understanding of the function of placental metabolic enzymes and transporters should add to the knowledge of the role of the tissue in the disposition of methadone and its relation to neonatal outcome. We hypothesized that the expression and activity of the placental efflux transporter P-glycoprotein (P-gp) would affect the transfer of methadone to the fetal circulation. Data obtained utilizing dual perfusion of placental lobule and monolayers of Be-Wo cell line indicated that methadone is extruded by P-gp. Transfer of methadone to the fetal circuit was increased by 30% in the presence of the P-gp inhibitor GF120918 while the transfer of paclitaxel, a typical substrate of the glycoprotein, was increased by 50%. In the Be-Wo cell line, methadone and paclitaxel uptake was also increased in the presence of the P-gp inhibitor cyclosporin A. Moreover, the expression of P-gp in placental brush-border membranes varied between term placentas. Taken together, these data strongly suggest that the concentration of methadone in the fetal circulation is affected by the expression and activity of P-gp. It is reasonable to speculate that placental disposition of methadone affects its concentration in the fetal circulation. If true, this may also be directly related to the incidence and intensity of neonatal abstinence syndrome (NAS).

AB - Methadone is the therapeutic agent of choice for treatment of the pregnant opiate addict. However, little is known on the factors affecting its concentration in the fetal circulation during pregnancy and how it might relate to neonatal outcome. Therefore, a better understanding of the function of placental metabolic enzymes and transporters should add to the knowledge of the role of the tissue in the disposition of methadone and its relation to neonatal outcome. We hypothesized that the expression and activity of the placental efflux transporter P-glycoprotein (P-gp) would affect the transfer of methadone to the fetal circulation. Data obtained utilizing dual perfusion of placental lobule and monolayers of Be-Wo cell line indicated that methadone is extruded by P-gp. Transfer of methadone to the fetal circuit was increased by 30% in the presence of the P-gp inhibitor GF120918 while the transfer of paclitaxel, a typical substrate of the glycoprotein, was increased by 50%. In the Be-Wo cell line, methadone and paclitaxel uptake was also increased in the presence of the P-gp inhibitor cyclosporin A. Moreover, the expression of P-gp in placental brush-border membranes varied between term placentas. Taken together, these data strongly suggest that the concentration of methadone in the fetal circulation is affected by the expression and activity of P-gp. It is reasonable to speculate that placental disposition of methadone affects its concentration in the fetal circulation. If true, this may also be directly related to the incidence and intensity of neonatal abstinence syndrome (NAS).

KW - Dual perfusion

KW - Human placenta

KW - Methadone

KW - P-Glycoprotein

KW - Transplacental transfer

UR - http://www.scopus.com/inward/record.url?scp=20344399858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344399858&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2005.03.030

DO - 10.1016/j.bcp.2005.03.030

M3 - Article

C2 - 15876424

AN - SCOPUS:20344399858

VL - 69

SP - 1869

EP - 1878

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -